- Home
- JPM vs LLY Comparison
JPM vs LLY Comparison
Compare JPM & LLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JPM
- LLY
- Stock Information
- Founded
- JPM 1799
- LLY 1876
- Country
- JPM United States
- LLY United States
- Employees
- JPM N/A
- LLY N/A
- Industry
- JPM Major Banks
- LLY Biotechnology: Pharmaceutical Preparations
- Sector
- JPM Finance
- LLY Health Care
- Exchange
- JPM Nasdaq
- LLY Nasdaq
- Market Cap
- JPM 694.6B
- LLY 755.9B
- IPO Year
- JPM N/A
- LLY N/A
- Fundamental
- Price
- JPM $263.06
- LLY $742.36
- Analyst Decision
- JPM Buy
- LLY Strong Buy
- Analyst Count
- JPM 17
- LLY 22
- Target Price
- JPM $250.53
- LLY $980.48
- AVG Volume (30 Days)
- JPM 10.9M
- LLY 3.7M
- Earning Date
- JPM 01-15-2025
- LLY 02-06-2025
- Dividend Yield
- JPM 1.90%
- LLY 0.81%
- EPS Growth
- JPM 21.69
- LLY 67.52
- EPS
- JPM 19.75
- LLY 9.25
- Revenue
- JPM $166,878,000,000.00
- LLY $40,863,300,000.00
- Revenue This Year
- JPM N/A
- LLY $34.73
- Revenue Next Year
- JPM $3.86
- LLY $28.78
- P/E Ratio
- JPM $13.32
- LLY $80.26
- Revenue Growth
- JPM 14.56
- LLY 27.41
- 52 Week Low
- JPM $168.44
- LLY $614.82
- 52 Week High
- JPM $264.23
- LLY $972.53
- Technical
- Relative Strength Index (RSI)
- JPM 74.76
- LLY 40.86
- Support Level
- JPM $252.14
- LLY $725.01
- Resistance Level
- JPM $245.69
- LLY $765.51
- Average True Range (ATR)
- JPM 5.13
- LLY 20.50
- MACD
- JPM 2.20
- LLY -3.83
- Stochastic Oscillator
- JPM 95.70
- LLY 21.59
About JPM JP Morgan Chase & Co.
JPMorgan Chase is one of the largest and most complex financial institutions in the United States, with nearly $4.1 trillion in assets. It is organized into four major segments--consumer and community banking, corporate and investment banking, commercial banking, and asset and wealth management. JPMorgan operates, and is subject to regulation, in multiple countries.
About LLY Eli Lilly and Company
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.